Abstract
Gene therapy has emerged as a promising approach for treating rare genetic diseases that have limited or no treatment options. By directly targeting the genetic mutations that cause these diseases, gene therapy offers the potential for long-lasting and, in some cases, curative treatments. Recent advances in gene editing technologies, viral vector systems, and delivery methods have accelerated the development of gene therapies for rare diseases. This article explores the latest advances in gene therapy, including the use of CRISPR-Cas9, viral and non-viral delivery systems, and ongoing clinical trials. It also discusses the challenges and future directions in the field, with a focus on improving the safety, efficacy, and accessibility of gene therapy for rare diseases.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2021 Dr. Michael Anderson (Author)